Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Krp-am1977
1. 848416-07-9
2. Lascufloxacin [inn]
3. 7-((3s,4s)-3-((cyclopropylamino)methyl)-4-fluoropyrrolidin-1-yl)-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid
4. Lasvic
5. Unii-55mob566v7
6. 55mob566v7
7. 3-quinolinecarboxylic Acid, 7-((3s,4s)-3-((cyclopropylamino)methyl)-4-fluoro-1-pyrrolidinyl)-6-fluoro-1-(2-fluoroethyl)-1,4-dihydro-8-methoxy-4-oxo-
8. 7-[(3s,4s)-3-[(cyclopropylamino)methyl]-4-fluoropyrrolidin-1-yl]-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxoquinoline-3-carboxylic Acid
9. 7-[(3s,4s)-3-[(cyclopropylamino)methyl]-4-fluoropyrrolidine-1-yl]-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid
10. 7-{(3s,4s)-3-[(cyclopropylamino)methyl]-4-fluoropyrrolidine-1-yl}-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid
11. Schembl501128
12. Lascufloxacin [who-dd]
13. Krp-am1977
14. Gtpl10823
15. Zfiocuittuuvpv-meduhntesa-n
16. Dtxsid001336967
17. Bcp29461
18. Ex-a5300
19. Akos040733577
20. Hy-16745
21. Cs-0012345
22. Krp-am1977; Krp-am-1977; Krp-am 1977
23. Q27261317
| Molecular Weight | 439.4 g/mol |
|---|---|
| Molecular Formula | C21H24F3N3O4 |
| XLogP3 | 0.8 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 8 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 82.1 |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 735 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01M - Quinolone antibacterials
J01MA - Fluoroquinolones
J01MA25 - Lascufloxacin
Market Place
ABOUT THIS PAGE
50
PharmaCompass offers a list of Lascufloxacin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lascufloxacin manufacturer or Lascufloxacin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lascufloxacin manufacturer or Lascufloxacin supplier.
PharmaCompass also assists you with knowing the Lascufloxacin API Price utilized in the formulation of products. Lascufloxacin API Price is not always fixed or binding as the Lascufloxacin Price is obtained through a variety of data sources. The Lascufloxacin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Lascufloxacin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lascufloxacin, including repackagers and relabelers. The FDA regulates Lascufloxacin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lascufloxacin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lascufloxacin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Lascufloxacin supplier is an individual or a company that provides Lascufloxacin active pharmaceutical ingredient (API) or Lascufloxacin finished formulations upon request. The Lascufloxacin suppliers may include Lascufloxacin API manufacturers, exporters, distributors and traders.
click here to find a list of Lascufloxacin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Lascufloxacin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lascufloxacin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lascufloxacin GMP manufacturer or Lascufloxacin GMP API supplier for your needs.
A Lascufloxacin CoA (Certificate of Analysis) is a formal document that attests to Lascufloxacin's compliance with Lascufloxacin specifications and serves as a tool for batch-level quality control.
Lascufloxacin CoA mostly includes findings from lab analyses of a specific batch. For each Lascufloxacin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lascufloxacin may be tested according to a variety of international standards, such as European Pharmacopoeia (Lascufloxacin EP), Lascufloxacin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lascufloxacin USP).
